Risk of COVID-19 Infection After Full Immunization in Patients With Inflammatory Bowel Disease on Treatment: A Research Network Analysis

Background: Acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is an issue in treating patients with Inflammatory Bowel Disease (IBD) due to concerns for infection risk and poor post-vaccination antibody response. We examined the potential impact of IBD treatments on SARS-CoV-2 infection rates af...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomanguillo, Julton, Searls, Lauren, Annie, Frank H, Kemper, Suzanne, Naravadi, Vishnu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939048/
https://www.ncbi.nlm.nih.gov/pubmed/36811056
http://dx.doi.org/10.7759/cureus.34004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939048/
https://www.ncbi.nlm.nih.gov/pubmed/36811056
http://dx.doi.org/10.7759/cureus.34004

Ejemplares similares